Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Kloss Silverman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|February 21, 2018
Sequential parallel comparison design with binary and time-to-event outcomesRachel Kloss Silverman, Anastasia Ivanova, Jason Fine
Abdominal Radiology (New York)|July 20, 2017
New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer?Jamie N Holtz, Rachel Kloss Silverman, Kae Jack Tay, et al.
AJR. American Journal of Roentgenology|April 12, 2016
Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?Rajan T Gupta, Alison Flanagan Brown, Rachel Kloss Silverman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2021
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell CarcinomaDavid F McDermott, Jae-Lyun Lee, Marek Ziobro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2021
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell CarcinomaDavid F McDermott, Jae-Lyun Lee, Georg A Bjarnason, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|February 21, 2018
Sequential parallel comparison design with binary and time-to-event outcomesRachel Kloss Silverman, Anastasia Ivanova, Jason Fine
Abdominal Radiology (New York)|July 20, 2017
New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer?Jamie N Holtz, Rachel Kloss Silverman, Kae Jack Tay, et al.
AJR. American Journal of Roentgenology|April 12, 2016
Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?Rajan T Gupta, Alison Flanagan Brown, Rachel Kloss Silverman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2021
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell CarcinomaDavid F McDermott, Jae-Lyun Lee, Marek Ziobro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2021
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell CarcinomaDavid F McDermott, Jae-Lyun Lee, Georg A Bjarnason, et al.
Pageof 1